Eosinophil-active chemokines: Assessment of in vivo activity

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 1, 1998, Pages 19-24

  Teixeira, M M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chemokine receptors; Chemokines; Eosinophils; Eotaxin; MIP 1

Indexed keywords

MURINAE;

CHEMOKINE; CHEMOKINE RECEPTOR;

ANIMAL; ARTICLE; COMPARATIVE STUDY; EOSINOPHIL; MOUSE; PHYSIOLOGY;

ANIMALS; CHEMOKINES; EOSINOPHILS; MICE; RECEPTORS, CHEMOKINE;

EID: 0031610683     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998000100003     Document Type: Article

References (34)

1. Butterworth AE & Thorne KJI (1993). Eosinophils and parasitic diseases. In: Smith R & Cook RM (Editors), Immunopharmacology of Eosinophils. Academic Press, London, 119-150.
2. Butterfield JH & Leiferman KM (1993). Eosinophil-associated diseases. In: Smith R & Cook RM (Editors), Immunopharmacology of Eosinophils. Academic Press, London, 152-192.
3. McLaren DJ (1980). Schistosoma mansoni: the Parasite Surface in Relation to Host Immunity. Research Studies Press, Chichester, UK.
4. Weller PF (1991). The immunobiology of eosinophils. New England Journal of Medicine, 324: 1110-1118.
5. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH & Holgate ST (1990). Mucosal inflammation in asthma. American Review of Respiratory Disease, 142: 434-457.
6. Teixeira MM. Williams TJ & Hellewell PG (1995). Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo. Trends in Pharmacological Sciences, 16: 418-423.
7. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76: 301-314.
8. Carlos TM & Harlan JM (1994). Leukocyte-endothelial adhesion molecules. Blood, 84: 2068-2101.
9. Varki A (1994). Selectin ligands. Proceedings of the National Academy of Sciences, USA, 91: 7390-7397.
10. Sriramarao P, von Andrian UH, Butcher EC, Bourdon MA & Broide DH (1994). L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. Journal of Immunology, 153: 4238-4246.
11. Schall TJ & Bacon KB (1994). Chemokines, leukocyte trafficking and inflammation. Current Opinion in Immunology, 6: 865-873.
12. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C & Sodroski J (1996). The ß-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell, 85: 1135-1148.
13. Power CA & Wells TNC (1996). Cloning and characterization of human chemokine receptors. Trends in Pharmacological Sciences, 17: 209-213.
14. Murphy PM (1996). Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine and Growth Factor Reviews, 7: 47-64.
15. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, Newman W, Gerard C & Mackay CR (1996). Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. Journal of Experimental Medicine, 183: 1-12.
16. Daugherty BL, Siciliano SJ, DeMartino J, Malkowitz L, Sirontino A & Springer MS (1996). Cloning, expression and characterization of the human eosinophil eotaxin receptor. Journal of Experimental Medicine, 183: 2349-2354.
17. Kita H & Gleich GJ (1996). Chemokines active on eosmophils: Potential roles in allergic inflammation. Journal of Experimental Medicine, 183: 2421-2426.
18. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E & Schröder J-M (1992). Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. Journal of Experimental Medicine, 176: 587-592.
19. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ & Dahinden CA (1992). RANTES and macrophage inflammatory protein 1-α induce the migration and activation of normal human eosinophil granulocytes. Journal of Experimental Medicine, 176: 1489-1495.
20. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ & Williams TJ (1994). Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. Journal of Experimental Medicine, 179: 881-887.
21. Uguccioni M, Loetscher P, Forssmann U, Dewald B, Li H, Lima SH, Li Y, Kreider B, Garotta G, Thelen M & Baggiolini M (1996). Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. Journal of Experimental Medicine, 183: 2379-2384.
22. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, Smith H, Shi X, Gonzalo J-A, Newman W, Gutierrez-Ramos J-C & Mackay CR (1996). Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding and functional properties provide a mechanism for the selective recruitment of eosinophils. Journal of Clinical Investigation, 97: 604-612.
23. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P & Luster AD (1996). Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Medicine, 2: 449-456.
24. Weber M, Uguccioni M, Ochensberger B, Baggiolini M, Clark-Lewis I & Dahinden CA (1995). Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. Journal of Immunology, 154: 4166-4172.
25. Dent LA, Strath M, Mellor AL & Sanderson CJ (1990). Eosinophilia in transgenic mice expressing interleukin 5. Journal of Experimental Medicine, 172: 1425-1431.
26. Teixeira MM, Williams TJ & Hellewell PG (1996). Recruitment of eosinophils by chemokines and other chemoattractants in an in vivo mouse model. British Journal of Pharmacology, 119: 52P (Abstract).
27. Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ & Williams TJ (1993). The chemokine, eotaxin, activates guinea-pig eosinophils in vitro, and causes their accumulation into the lung in vivo. Biochemical and Biophysical Research Communications, 197: 1167-1172.
28. Gonzalo J-A, Jia G-Q, Aguirre V, Friend D, Coyle AJ, Jenkins NA, Lin G-S, Katz H, Lichtman A, Copeland N, Kopf M & Gutierrez-Ramos J-C (1996). Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity, 4: 1-14.
29. Jose PJ, Adcock IM, Griffiths-Johnson DA, Berkman N, Wells TNC, Williams TJ & Power CA (1994). Eotaxin: Cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs Biochemical and Biophysical Research Communications, 205: 788-794.
30. Rothenberg ME, Luster AD, Lilly CM, Drazen JM & Leder P (1995). Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. Journal of Experimental Medicine, 181: 1211-1216.
31. Post TW, Bozic CR, Rothenberg M E, Luster AD, Gerard N & Gerard C (1995). Molecular characterization of two murine eosinophil ß chemokine receptors. Journal of Immunology, 155: 5299-5306.
32. Lukacs NW, Strieter RM, Shaklee CL, Chensue SW & Kunkel SL (1995). Macrophage inflammatory protein-1α influences eosinophil recruitment in antigen-specific airway inflammation. European Journal of Immunology, 25: 245-251.
33. Meurer R, van Riper G, Feeney W, Cunningham P, Hora D, Springer MS, MacIntyre DE & Rosen H (1993). Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1α or human interleukin 8. Journal of Experimental Medicine, 178: 1913-1921.
34. Sehmi R, Cromwell O, Wardlaw AJ, Moqbel R & Kay AB (1993). Interleukin-8 is a chemoattractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clinical and Experimental Allergy, 23: 1027-1036.